COVID-19 Vaccine

Get the latest information from Ochsner LSU Health on what you need to know about the COVID-19 vaccine.

Thursday, May 13, 2021 Update

On May 10, 2021, Pfizer received FDA approval under Emergency Authorization Use (EUA) to expand vaccination to children ages 12-15 based on new trial data. Ochsner LSU Health is now scheduling for anyone ages 12 years or older to receive the Pfizer COVID-19 vaccine. Ochsner LSU Health only recommends and administers vaccines that the Food and Drug Administration has certified as safe and effective for all patients and employees, including our most vulnerable populations. The benefits of vaccination greatly outweigh the risks of forgoing immunization for your child. Data specific to the 12-15-year-old group shows 100% efficacy, robust antibody responses and was well tolerated. Consent by a parent or guardian is required for anyone under 18. Consent can be provided through MyChart, during e-Pre Check, through a witnessed legal consent form, or in person at the vaccination location. In accordance with Louisiana's new mask mandate, Ochsner LSU Health still requires the use of masks at all hospitals and clinics.

Vaccine Appointment Available Now

We are offering scheduling for new first dose appointments at select locations on a first-come, first-served basis.

Anyone age 18 years or older is eligible for all COVID-19 vaccines and anyone who 12 years or older is eligible for the Pfizer vaccine in Louisiana.

MyChart users can check availability and schedule their vaccinations via MyChart. If you have never been to an Ochsner location before and do not have a MyChart account, you can sign up at my.ochsner.org/lsu, or call 318-626-0050 for Shreveport locations and 318-330-7599 for Monroe. Appointments are encouraged and walk-ups are welcome.

MyChart Call 318-626-0050 for Shreveport Call 318-330-7599 for Monroe


Community Vaccination Events

Get the latest schedule of vaccination events.

Vaccine Events

We appreciate your willingness to be part of the solution as we work together to end this pandemic.


Answers to your Frequently Asked Questions about the COVID-19 Vaccine

Pfizer Vaccine for Ages 12-15

  • Yes, Ochsner Health and Ochsner Hospital for Children continue to encourage all eligible community members to get the COVID-19 vaccine to protect themselves and others and ultimately end this pandemic.
  • The vaccine is endorsed by the American Academy of Pediatrics which says “the COVID-19 vaccine is our best hope for ending the current pandemic” and urges youths and adults to get the vaccine as soon as it is available to them.
  • Ochsner Health and Ochsner Hospital for Children participated in the adolescent Pfizer 12-17-year-old vaccine trial, which means our patients contributed to the safety data submitted to FDA.
  • Data specific to the 12-15-year-old group shows 100% efficacy, robust antibody responses and was well tolerated.
  • Although children and teenagers are at less risk of severe complications from COVID-19, the virus has still seriously impacted millions of children and teens across the globe.
  • Children and teenagers who have COVID-19 may have no symptoms but are still able to transmit the virus to their parents, grandparents, teachers, friends and loved ones.
  • Vaccinating children and teens for COVID-19 should be treated just like any other routine vaccination. In the same way that children are vaccinated for the measles, mumps and chicken pox, they should also be vaccinated for COVID-19.
  • No, as with any vaccination, it is required that a child under the age of 18 must have parental or guardian consent.
  • Consent by a parent or guardian is required for anyone under 18. Consent can be provided through MyOchsner, during ePreCheck, through a witnessed legal consent form, or in person at the vaccination location.
  • Please note, if your child does not already have a MyOchsner account, you must fill out a request form which has a turnaround time of 1 to 3 days.
    • If the custodial parent has a MyChart account, they can request access online using the form under the Main Menu >> Sharing >> Request Access.
    • If the custodial parent does NOT have a MyChart account, they can click here to sign up and put in a request. They will receive a notification and an email with this information as well.
  • Ochsner Health and Ochsner Hospital for Children have plenty of availability across the system! We offer vaccinations at our hospitals, retail pharmacy locations, mass vaccination sites and community vaccine events across the state. We continue to add more locations and events each week to make it as convenient as possible for your child to receive the vaccine.
  • You can schedule your child’s vaccination appointment via MyOchsner or by calling 1-844-888-2772. You can also check out open vaccine appointments at Ochsner.org/appointment-availability.
  • Please note, if your child does not already have a MyOchsner account, you must fill out a request form which has a turnaround time of 1 to 3 days.
    • If the custodial parent has a MyChart account, they can request access online using the form under the Main Menu >> Sharing >> Request Access.
    • If the custodial parent does NOT have a MyChart account, they can still click here to sign up and put in a request. They will receive a notification and an email with this information as well.
  • Pfizer recently received FDA approval under Emergency Authorization Use (EUA) to expand vaccination to children ages 12-15 based on new trial data.
  • Just like the three vaccines currently being administered under EUA, the FDA and the U.S. Department of Health and Human Services have assured the public that no safety or efficacy evaluation steps have been skipped in approving the vaccine.
  • Ochsner Health and Ochsner Hospital for Children remain committed to educating our patients about the COVID-19 vaccines so they can make informed decisions for themselves and their family.
  • The FDA amended the EUA originally issued on December 11, 2020 to include adolescents 12 – 15 years of age on May 10, 2021.
  • The Pfizer vaccine is now available for teenagers ages 12-15. You can schedule your vaccination appointment via MyOchsner or by calling 1-844-888-2772. You can also see which Ochsner regions across the state have vaccine availability.
  • Pfizer completed its adolescent trial for children ages 12-17 earlier this year. Results from the trial for children ages 16-17 showed the vaccine is safe and effective and granted EUA approval on December 11, 2020.
  • The results of Pfizer’s 12–15-year-old age group shows 100% efficacy, robust antibody responses and was well tolerated. Based on both sets of successful results, Pfizer again applied for EUA status which was granted on May 10, 2021.
  • No, it is the same two-dose regimen currently being administered to those who are ages 16 and older. Data specific to the 12-15-year-old group shows 100% efficacy, robust antibody responses and was well tolerated.
  • Yes, the same dosage is the same for all adolescents and adults ages 12 and older.
  • At this time, there is no indication that a third shot is needed. There are currently ongoing trials reviewing a potential booster/third shot for adults.
  • Your child will need to receive two doses, scheduled 21 days apart, to be fully effective and provide the most protection.
  • Trial data presented in the EUA demonstrated 100% efficacy, robust antibody responses and was well tolerated in children ages 12-15.
  • Moderna completed its COVID-19 vaccine trial for children ages 12-15 in February 2021 and anticipates results for this trial by mid-year.
  • The vaccine was studied in adults first before expanding to include younger age groups.
  • In October 2020, Pfizer received approval to enroll children as young as 12 into the trial. The results of Pfizer’s trial in the 12 to 15-year-old age group show the vaccine was 100% effective against COVID-19 and was well tolerated.
  • And, Ochsner Health participated in the adolescent Pfizer vaccine trial, which means our patients contributed to the safety data submitted to FDA.
  • As a destination for pediatric care, Ochsner Health and Ochsner Hospital for Children are committed to playing a key role in identifying a safe and effective vaccine for the benefit of all – including adolescents.
  • Ochsner Health and Ochsner Hospital for Children’s contributions to the adolescent Pfizer vaccine trial (ages 12-17) have helped illustrate their safety to the FDA.
  • Ochsner Health and Ochsner Hospital for Children will only recommend and administer vaccines that the Food and Drug Administration has certified as safe and effective for all patients and employees, including our most vulnerable populations. The benefits of vaccination greatly outweigh the risks of forgoing immunization for your child. Data specific to the 12-15-year-old group shows 100% efficacy, robust antibody responses and was well tolerated.
  • Following guidelines from the FDA EUA, no one is excluded from receiving the vaccine. The only medical contraindications to receiving this vaccine are severe allergic reaction after a previous dose of this vaccine or severe allergic reaction to components of this vaccine.
  • It is important to have this discussion with your pediatrician to determine if this is the best decision for your child.
  • Yes. There is not enough information currently available to say how long after infection someone is protected from getting COVID-19 again. To stop this pandemic, we need to use every tool available which includes immunization, social distancing, handwashing and wearing masks.
  • The CDC now recommends that other vaccines can be given with the COVID-19 vaccine.
  • It is important that children who may have missed doses of routine vaccines during the pandemic complete or catch up with these routine immunizations.
  • Ochsner Health and Ochsner Hospital for Children have plenty of availability across the system! We offer vaccinations at our hospitals, retail pharmacy locations, mass vaccination sites and community events across the state. Due to the temperature and other preparation requirements to properly dispense the COVID-19 vaccine, Ochsner Hospital for Children is not currently administering the COVID-19 vaccines at pediatrician offices. We continue to add more locations and events each week to make it as convenient as possible for your child to receive the vaccine.
  • Children can become infected and transmit to other people as well as be symptomatic or asymptomatic just like adults.
  • · While a child’s risk of dying from COVID-19 is very low — under 0.03 percent -- the most common complication of the disease is multisystem inflammatory syndrome in children (MIS-C).
  • Yes. Though Gov. John Bel Edwards partially lifted Louisiana’s statewide mask mandate, masks are still required in schools, hospitals, clinics and other specific locations.
  • We must all continue to wear masks until we reach herd immunity, which occurs when enough people become immune to a disease to make its spread unlikely.
  • Pfizer reports the side effects found in children during its trial were generally consistent with those found in adults immediately following vaccination.
  • As is the case with any vaccine, allergic reactions may occur. Some may experience mild fever, soreness, muscle aches, headaches, chills, tiredness and redness or swelling at the site of administration. These are signs of an immune response to the vaccine and are expected in some patients.
  • It is common for children to experience fever after any vaccination; this is an anticipated side effect.
  • While extreme serious reactions to the vaccine are rare, you should seek medical care if:
    • Your child experiences a severe allergic reaction (call 911 or go to the nearest ER)
    • The side effects do not seem to be going away or are getting worse after a few days.
  • We do not recommend pre-treating your child with pain or fever reducers because it may weaken your child’s immune response to vaccines.
  • After the vaccine, you may give your child a pain or fever reducers if needed.
  • While every individual is unique, there are no indications that reactions run in families.
  • There is no evidence that the COVID-19 vaccine affects child development, puberty or fertility.

J&J Vaccine

  • On April 13, federal health agencies called for an immediate pause in use of Johnson & Johnson’s single-dose COVID-19 vaccine after eight recipients in the United States developed a rare blood clot disorder, cerebral venous sinus thrombosis, within two weeks of vaccination.
  • This decision was made so that it could be investigated to determine if there is a correlation between the vaccine and this medical condition.
  • On April 23, these federal health agencies recommended resumed use of the Johnson & Johnson vaccine in the United States.
  • Click here to view the J&J EUA fact sheet
  • The safety of our patients and community is our highest priority. At the recommendation of CDC and FDA, Ochsner Health paused J&J vaccine effective immediately. We will continue to follow CDC and FDA guidance.
  • On April 23, these federal health agencies recommended resumed use of the Johnson & Johnson vaccine in the United States.
  • Yes. When you book your vaccine, you will be able to choose which vaccine you would prefer, and available appointments will show for that vaccine only.
  • The type of vaccine available at each site is dependent upon supply.
  • Yes, on April 23 FDA and CDC determined that the recommended pause regarding the use of the Johnson & Johnson (Janssen) COVID-19 vaccine in the U.S. should be lifted and use of the vaccine should resume.
  • The FDA and CDC have confidence that this vaccine is safe and effective in preventing COVID-19.
  • The Pfizer and Moderna vaccines are two shots each – one shot followed by a booster either 19 - 23 or 26 - 30 days later depending on the vaccine. Each uses mRNA, or messenger RNA, which gives cells instructions to create a protein like the SAR-CoV2 protein. Once the protein is created, it triggers the immune response leading to the production of antibodies.
  • The J&J vaccine uses one shot. It utilizes the adenoviruses which are the same viruses that can cause the common cold. These inactivated/non-infective adenoviruses can be used to deliver DNA, which are instructions for proteins. For the COVID-19 vaccine, researchers swap in a gene from SARS-CoV-2 (COVID-19) so that the modified cold virus makes the SARS-CoV2 protein, stimulating production of antibodies and additional immune responses to fight off the virus. The process creates an immune memory, which ultimately teaches the body to both recognize and attack the virus.
  • It is normal to have flu-like symptoms after being given a vaccination. They are reported be generally mild to moderate, resolving within 1-2 days, with 1% to 2% reported as severe. View the list of potential side effects here.
  • People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider.
  • There is an extremely remote potential of developing a rare blood clot disorder -- less than one case per million doses given -- called cerebral venous sinus thrombosis (CVST), within two weeks of vaccination.
  • CVST is a rare form of stroke, affecting 5 people in 1 million every year.
  • Your likelihood of developing CVST is very low, but you should seek medical attention if you experience the severe symptoms listed above. The six patients who developed CVST experienced symptoms 6-13 days following their vaccinations. Although significant side effects are rare, it’s recommended that you share you’ve recently been vaccinated with doctors if you are seeking treatment.
  • It is normal to have flu-like symptoms after being given a vaccination. People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider.

Vaccine Scheduling

  • We are scheduling new first dose appointments at select locations on a first come, first serve basis for those who meet the eligibility criteria.
  • MyChart users can schedule their vaccinations via MyChart or by calling 318-626-0050 for Shreveport or 318-330-7599 for Monroe. You can also see which Ochsner regions across the state have vaccine appointments at Ochsner.org/appointment-availability.
  • Patients receiving Pfizer or Moderna vaccines will schedule their first dose via MyChart or by calling. Your second dose is guaranteed. Ochsner LSU Health will notify you of the exact date and time of your second dose appointment via text and email within 24 hours of when your first dose is administered.
  • If you have never been to an Ochsner LSU Health location before and do not have a MyChart account, we encourage you to enroll at my.ochsner.org/lsu. This is a secure portal that allows patients to view test results, message their providers and schedule appointments at the click of a button.
  • Once available vaccine slots are filled on MyChart, you will no longer be able to see the option to book.
  • Those who are eligible will be required to attest that they meet the criteria and may be asked to provide proof. A full list of the criteria can be found at covidvaccine.la.gov.
  • More times and dates will become available as we receive more vaccine each week. We encourage you to continue to check MyChart and Ochsner.org/appointment-availability as more appointments become available and appreciate your patience during this process.
  • As eager as we are to vaccinate as many patients as possible, you must have a scheduled appointment to receive the vaccine.
  • We appreciate your willingness to be part of the solution to end this pandemic.
  • Effective Monday, March 29, anyone age 18 years or older is now eligible for the Moderna and Pfizer COVID-19 vaccines and anyone who 16 years or older is eligible for the Pfizer vaccine in Louisiana.
  • Anyone age 18 years or older is now eligible for the Moderna and Pfizer COVID-19 vaccines and anyone who 16 years or older is eligible for the Pfizer vaccine in Louisiana.
  • We are scheduling new first dose appointments and also encourage you to check your state’s department of health website for vaccine availability and locations.
  • If you are receiving a Pfizer or Moderna vaccine, your second dose appointment will automatically be scheduled once you have received your first dose. It will be scheduled at the correct interval of time from your first dose: 19 – 23 days for Pfizer, or 26 - 30 days for Moderna, from your first dose.
  • Ochsner LSU Health will notify you of the exact date and time of your second dose appointment via text and email within 24 hours of when your first dose is administered.
  • All second dose appointments will be administered at the same location as first dose appointments.
  • As with any appointment type, you can call our contact center at 1-844-888-2772 to verify the date and time of your second dose appointment.
  • We ask that patients keep their second dose appointments as they are scheduled, but we understand that sometimes appointment times no longer work.

Vaccine Safety, Effectiveness and Side Effects

  • The Pfizer, Moderna and AstraZeneca/University of Oxford vaccines are two shots – one shot followed by a booster either 21 or 28 days depending on the vaccine. Each uses mRNA, or messenger RNA, which gives cells instructions to create a protein like the SAR-CoV2 protein. Once the protein is created, it triggers the immune response leading to the production of antibodies.
  • The Janssen vaccine uses one shot. It utilizes the adenoviruses which are the same viruses that can cause the common cold. These inactivated/non-infective adenoviruses can be used to deliver DNA, which are instructions for proteins. For the COVID-19 vaccine, researchers swap in a gene from SARS-CoV-2 (COVID-19) so that the modified cold virus makes the SARS-CoV2 protein, stimulating production of antibodies and additional immune responses to fight off the virus. The process creates an immune memory, which ultimately teaches the body to both recognize and attack the virus.
  • Following guidelines from the FDA emergency use authorization (EUA), no one is excluded from receiving the vaccine as there are no medical contraindications except for a severe allergic reaction to this vaccine or any of its components.
  • Because the Pfizer and Moderna vaccines require two doses, MyChart or the COVID hotline will automatically schedule the second dose at the same location with the appropriate length of time (21 or 28 days depending on which vaccine you receive) between visits. You must be able to attend the second appointment in order to schedule the first.
  • Most commonly used in clinical trials, vaccine efficacy is a percentage measured by calculating the risk of disease among vaccinated and unvaccinated persons.
  • For example, vaccine efficacy of 90% means a 90% reduction from the number of cases you would expect if they have not been vaccinated.
  • Vaccine effectiveness is different and shows the ability of vaccine to prevent outcomes of interest in the “real world.
  • Each trial sponsor needs to review to see if any such potential process and amendment to the original protocol (where participants stay blinded for the 24-month duration of the study) would be subject to the input of the regulatory authorities.
  • If you are currently a participant in one of the Ochsner vaccine trials, please contact your study staff for more information.
  • No COVID-19 vaccine trial has been canceled. Two trials were paused which is normal for all clinical trials to take a closer look at symptoms participants develop to see if there are possible side effects. Sometimes the symptoms have nothing to do with the actual product. This process is in place to ensure that any product brought to the public is as safe as possible. Both trials that were paused were resumed once an independent safety monitoring board deemed the side effects not related to the vaccine.
  • Ochsner Health fully supports and highly encourages widespread vaccination under the Emergency Use Authorization (EUA) for all employees and our patients. Large scale vaccination of our community is the best way to keep everyone safe and to end the COVID-19 pandemic.
  • Since this is a novel virus, we are still unsure how long the vaccine antibodies will last. We are closely monitoring the research as more data becomes available.
  • Like the flu shot, the vaccine is administered into a large muscle in the upper arm. As is the case with any vaccine, allergic reactions may occur. Some may experience mild fever, soreness, muscle aches, headaches, chills, fatigue/tiredness, muscle or joint pain, redness and/or swelling at the site of administration. These are signs of an immune response to the vaccine and expected in some patients.
  • Based on data reported from the FDA emergency use authorization (EUA), possible side effects have been more prominent after the second dose of Pfizer or Moderna.
  • If you have pain or discomfort, you can take your normal pain reliever or talk to your pharmacist about taking an over-the-counter medicine, such as ibuprofen or acetaminophen.
  • To reduce pain and discomfort where you got the shot, you can apply a clean, cool compress over the area. To reduce discomfort from fever, drink plenty of fluids.
  • While extreme serious reactions to the vaccine are rare, you should seek medical care if:
    • you experience a severe allergic reaction call 911 or go to the nearest emergency room
    • the redness or tenderness where you got the shot increases after 24 hours
    • your side effects are worrying you or do not seem to be going away after a few days
  • Ochsner On Call can answer questions at 800-231-5257 or 504-842-3155
  • If you are experiencing an emergency, call 911.
  • Report side effects to FDA/CDC Vaccine Adverse Event Reporting System (VAERS). Reporting instructions are included in Fact Sheet you received when you got your vaccine.
  • We recommend that people continue their routine medications as prescribed by their physician which may include aspirin, ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn), also known as nonsteroidal anti-inflammatory drug (NSAID). Patients who have one of the CDC-listed underlying medical conditions and are prescribed NSAID by their physicians, are not excluded and are encouraged to receive the vaccine
  • It is generally recommended to avoid scheduling “routine” immunizations 14 days before or after your scheduled COVID-19 vaccination. If other vaccines are administered, there is no need to alter the COVID-19 immunization schedule or repeat any of the immunizations.
  • The vaccine cannot cause you to test positive via nasal swab or saliva test. This is not a live vaccine and will not cause you to shed virus.
  • Some patients may still become infected or develop symptoms following vaccination against COVID-19. However, the current vaccines under consideration all have greater than 90% efficacy of preventing you from getting infected. They also have demonstrated that your risk of a severe infection that requires you to be hospitalized is greatly reduced following immunization.
  • That is the intent. Instead of traditional vaccines, which may use the virus itself, the SARS-CoV-2 vaccine will use a protein on the outside of the virus. This means the vaccine can’t cause COVID-19 in a person, because it’s not using the virus that causes the disease.
  • This stimulates your body’s immune system to mount a response as if it were a true infection, minimizing your risk of infection or disease burden should you encounter the same virus later. The current vaccine candidates have been demonstrated to be over 90% effective in preventing you from developing symptomatic infection from COVID-19.
  • However, in order to stop this pandemic, we need to use every tool available which includes the immunization, social distancing, handwashing and wearing masks.
  • No, there are no restrictions after receiving a COVID-19 vaccine, but you should continue to wear your mask, social distance and practice good hand hygiene.
  • Yes. Remember, it takes time for your body to build protection after any vaccination. COVID-19 vaccines that require 2 shots may not protect you until at least a week after your second shot.
  • It’s important for everyone to continue using all the tools available to help stop this pandemic as we learn more about how COVID-19 vaccines work in real-world conditions.
  • Until we reach herd immunity and the majority of the United States has been vaccinated, we will need to continue to practice social distancing, handwashing and wearing masks. These are the best ways to reduce your chance of being exposed to or spreading the virus until we end this pandemic.
  • Yes. There is not enough information currently available to say how long after infection someone is protected from getting COVID-19 again. In order to stop this pandemic, we need to use every tool available which includes the immunization, social distancing, handwashing and wearing masks.
  • No deferral is necessary for whole blood or platelet donors who received non-replicating, inactivated or RNA-based vaccines or the mRNA Pfizer-BioNTech or Moderna COVID-19 vaccines.
  • No. The FDA does not feel that it would be acceptable for these individuals to donate CCP. This is because it is not known yet if the CCP would be efficacious from a vaccinated person.

Different Types of Vaccines Questions

  • It is not uncommon to have multiple pharmaceutical manufacturers produce and distribute a vaccine against the same preventable disease. In fact, numerous vaccines, such as those for influenza and DTaP (diphtheria, tetanus and pertussis) are well-known and common vaccines who use several different manufacturers for vaccine development and distribution.
  • The series and dosing for each vaccine is based on the initial results from the clinical trial data. Just because some vaccines may have one shot vs two, doesn’t mean that one is less effective than the other.
  • To best maximize the efficacy of the vaccine and to ensure an optimal effectiveness, it is highly recommended that you receive the second dose within the specified timeframe as directed by the manufacturer. If you don’t receive the second shot, you will greatly decrease the chance of the vaccine working.

Vulnerable Populations

  • COVID-19 vaccination may not be for everyone. If you are unsure if you should receive the COVID-19 vaccine, please call your healthcare provider to discuss the possible benefits and risks.
  • Following guidelines from the FDA, no one is excluded from receiving the vaccine, even patients who are pregnant or breastfeeding. The only medical contraindications to receiving this vaccine are severe allergic reaction after a previous dose of this vaccine or severe allergic reaction to components of this vaccine. If you have an individual question regarding a medical condition, you can contact us at vaccine@ochsner.org.

Based on trial data, people ages 16 and 17 are eligible to receive the Pfizer vaccine under Louisiana’s eligibility criteria.

    • Adolescent patients under 18 will be required to have a parent or guardian present when being immunized.
    • Additionally, there are a few trials that are enrolling various age groups including children ages 12 or greater with new trials for lower age groups that start as young as six months old.
    • Just like the adult COVID-19 vaccine trials, data from children and adolescent COVID-19 vaccine trials will need to support the safety and efficacy of the vaccines before FDA EUA approval for the population.
    • Ochsner will only recommend and administer vaccines that have been evaluated for safety, effectiveness and individual patient needs.
    • The benefits of vaccination outweigh the risks of forgoing immunization.
  • The claim circulating on social media that the COVID-19 vaccine causes female infertility is FALSE and is not supported by any research. Following guidelines from the FDA, no one is excluded from receiving the vaccine, even patients who are pregnant or breastfeeding, as there are no medical contraindications to receiving this vaccine. Ochsner is encouraging all employees and patients to receive the vaccine as soon as it’s available to them. You may review this advice from the Society for Maternal Fetal Medicine for those pregnant or breastfeeding.

Ochsner LSU Health Shreveport is always ready to provide the high-quality care you deserve!